Codexis, Inc.
0I0X.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$151.66M
Close$
Share Statistics
| Market cap | $151.66 Million |
|---|---|
| Enterprise Value | $197.94 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.5 |
| Beta | 2.5 |
| Outstanding Shares | 91,053,000 |
Return
| Return on Equity | -93.22% |
|---|---|
| Return on Assets | -25.59% |
| Return on Invested Capital | -28.22% |
Valuation & Multiples
| P/E Ratio | -4.2 |
|---|---|
| PEG | 43.97 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.55 |
| Enterprise Value to EBIT | -7.27 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 2.23 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$13.82 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$18.73 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Codexis Inc.
146 employees
CEO: Alison Moore Codexis, Inc. specializes in the invention, advancement, and commercialization of enzymes and various other proteins. Their diverse portfolio encompasses biocatalyst solutions, chemical intermediates designed for subsequent processing, a...